From the Journals

Breakthrough infections twice as likely to be asymptomatic


 

FROM THE LANCET INFECTIOUS DISEASES

The authors of the new research paper believe their findings may have implications for health policies regarding the timing between vaccine doses, COVID-19 booster shots, and for continuing personal protective measures.

The authors of the paper and Dr. Hijano disclosed no conflicts.

Pages

Recommended Reading

Children’s upper airways primed to combat SARS-CoV-2 infection
Journal of Clinical Outcomes Management
CDC panel unanimously backs Pfizer vax, fortifying FDA approval
Journal of Clinical Outcomes Management
Long COVID symptoms can persist for more than 1 year, study shows
Journal of Clinical Outcomes Management
Children and COVID: Weekly cases top 200,000, vaccinations down
Journal of Clinical Outcomes Management
‘Deeper dive’ into opioid overdose deaths during COVID pandemic
Journal of Clinical Outcomes Management
Two swings, two misses with colchicine, Vascepa in COVID-19
Journal of Clinical Outcomes Management
COVID-clogged ICUs ‘terrify’ those with chronic or emergency illness
Journal of Clinical Outcomes Management
Another COVID-19 patient to get ivermectin after court order
Journal of Clinical Outcomes Management
Even highly allergic adults unlikely to react to COVID-19 vaccine
Journal of Clinical Outcomes Management
2021 AGA Rapid Review and Guideline Update: Pre-endoscopy SARS-CoV-2 testing post vaccination
Journal of Clinical Outcomes Management